Throughput pressure vs result validation

On nights in our 280-bed hospital lab, I’m being pushed to auto-release CBCs despite failed delta checks or missing second-level QC, all in the name of TAT — with a CAP inspection due in March. How are you documenting refusals and escalating when CLIA/CAP policy says hold for manual review, especially when middleware rules in SoftLab were overridden by a supervisor? I want to protect patients and my license without becoming “that tech.”.

‌⁠‍⁠​‍​‍‌⁠‌​​‍​‍​⁠‍‍​‍​‍‌‍⁠​‌‍​‌‌‍​‍‌⁠‌​‌‍‌‌‌‍​⁠‌‍‍​‌‍⁠‍‌‍‍‌‌‍​⁠‌‍‍‌‌‍​‌‌‍⁠‍​‍​‍​‍⁠​​‍​‍‌‍‍⁠​‍​‍​⁠‍‍​‍​‍‌‍⁠‍‌‍‌‌‌⁠‌⁠‌‌⁠⁠‌⁠‌​‌‍⁠⁠‌⁠​​‌‍‍‌‌‍​⁠​‍​‍​‍⁠​​‍​‍‌‍‍‌‌‍‌​​‍​‍​⁠‍‍​‍​‍‌‍⁠‍‌‍‌‌‌⁠‌⁠​‍​‍​‍⁠​​‍​‍‌‍‌​​‍​‍​⁠‍‍​‍​‍​⁠​‍​⁠​​​⁠​‍​⁠‌‌​⁠​‌​⁠​‍​⁠​‍​⁠​‍​‍​‍​‍⁠​​‍​‍‌‍‍​​‍​‍​⁠‍‍​‍​‍‌⁠‌​‌‌⁠⁠‌⁠‍‌‌⁠‍​‌⁠‌​‌​⁠⁠‌​‍‍​⁠‌‍‌‍⁠‍‌‌⁠⁠‌‍​‍‌⁠​​‌‌​‌‌⁠​⁠‌⁠‌‌‌‌‌‌​‍​‍‌⁠⁠‌​

In SoftLab, add a standard exception comment that auto-attaches when a delta or 2nd-level QC fails — e.g., “Manual hold per policy — delta fail; released per [AB] at 02:14” — and submit a variance/NCE each time so QA and the lab director see the pattern. Ask LIS to lock the middleware rule behind change control and send a daily override audit to the medical director; if they won’t, park those cases in a ‘TAT exception’ manual-release queue so the TAT hit is visible. Paper trail thicker than a smear beats a CAP ding — do you have a QA meeting or minutes where you can anchor these variances?

‌⁠‍⁠​‍​‍‌⁠‌​​‍​‍​⁠‍‍​‍​‍‌‍⁠​‌‍​‌‌‍​‍‌⁠‌​‌‍‌‌‌‍​⁠‌‍‍​‌‍⁠‍‌‍‍‌‌‍​⁠‌‍‍‌‌‍​‌‌‍⁠‍​‍​‍​‍⁠​​‍​‍‌‍‍⁠​‍​‍​⁠‍‍​‍​‍‌⁠​‍‌‍‌‌‌⁠​​‌‍⁠​‌⁠‍‌​‍​‍​‍⁠​​‍​‍‌‍‍‌‌‍‌​​‍​‍​⁠‍‍​⁠​‌​⁠​‌​⁠‍​​‍⁠​​‍​‍‌‍‌​​‍​‍​⁠‍‍​‍​‍​⁠​‍​⁠​​​⁠​‍​⁠‌‌​⁠​‌​⁠​‍​⁠​‍​⁠‌​​‍​‍​‍⁠​​‍​‍‌‍‍​​‍​‍​⁠‍‍​‍​‍‌‌‌‌‌‌‌​​⁠‌‍‌‍‍‍‌‍‌‌‌⁠‍‌‌‍⁠‍‌​‍⁠‌‌‌​‌​​‍‌​⁠‌​⁠​‌‌‌‌⁠‌⁠‌‍‌​‌​‌‌‌‌​‍​‍‌⁠⁠‌​

Front-loading ‘WCAG 2.2 AA’ in design tokens and shared components; axe-core CI. Still split risky widgets; external audit?

‌⁠‍⁠​‍​‍‌⁠‌​​‍​‍​⁠‍‍​‍​‍‌‍⁠​‌‍​‌‌‍​‍‌⁠‌​‌‍‌‌‌‍​⁠‌‍‍​‌‍⁠‍‌‍‍‌‌‍​⁠‌‍‍‌‌‍​‌‌‍⁠‍​‍​‍​‍⁠​​‍​‍‌‍‍⁠​‍​‍​⁠‍‍​‍​‍‌⁠​‍‌‍‌‌‌⁠​​‌‍⁠​‌⁠‍‌​‍​‍​‍⁠​​‍​‍‌‍‍‌‌‍‌​​‍​‍​⁠‍‍​⁠​‌​⁠​‌​⁠‍​​‍⁠​​‍​‍‌‍‌​​‍​‍​⁠‍‍​‍​‍​⁠​‍​⁠​​​⁠​‍​⁠‌‌​⁠​‌​⁠​‍​⁠​‍​⁠‌‍​‍​‍​‍⁠​​‍​‍‌‍‍​​‍​‍​⁠‍‍​‍​‍‌‍​⁠‌​⁠⁠‌‌​‌‌‍‌‍‌‌‌‍‌​⁠⁠‌‍‍⁠‌‍⁠​‌​‌⁠‌‍‍‍‌‌​⁠‌⁠‍‍‌⁠‌⁠‌​‌⁠‌‍​⁠‌​⁠‌​‍​‍‌⁠⁠‌​

Building on @marthaV92, pair the auto-comment with a variance workflow: in real time send a one‑liner to the medical director, Quality, and the supervisor — “Policy deviation: auto‑release after delta fail; approved by [AB] at 02:14; MRN ####” — and file an RLDatix event so there’s a trace CAP will respect. Roll these into a shared override log the director signs weekly; CAP loves a paper trail more than we love coffee — do you have RLDatix or another incident system?

‌⁠‍⁠​‍​‍‌⁠‌​​‍​‍​⁠‍‍​‍​‍‌‍⁠​‌‍​‌‌‍​‍‌⁠‌​‌‍‌‌‌‍​⁠‌‍‍​‌‍⁠‍‌‍‍‌‌‍​⁠‌‍‍‌‌‍​‌‌‍⁠‍​‍​‍​‍⁠​​‍​‍‌‍‍⁠​‍​‍​⁠‍‍​‍​‍‌⁠​‍‌‍‌‌‌⁠​​‌‍⁠​‌⁠‍‌​‍​‍​‍⁠​​‍​‍‌‍‍‌‌‍‌​​‍​‍​⁠‍‍​⁠​‌​⁠​‌​⁠‍​​‍⁠​​‍​‍‌‍‌​​‍​‍​⁠‍‍​‍​‍​⁠​‍​⁠​​​⁠​‍​⁠‌‌​⁠​‌​⁠​‍​⁠​‍​⁠‍​​‍​‍​‍⁠​​‍​‍‌‍‍​​‍​‍​⁠‍‍​‍​‍‌​‍‌‌​‌‍‌⁠​​‌‌​‍‌‌​​‌​‍‌​⁠‍‌‌‌‌⁠‌‌‍​​⁠‍‌​⁠​‍‌‍​⁠​⁠‍​‌‍​⁠‌​⁠‌‌‍⁠⁠​‍​‍‌⁠⁠‌​

Export SoftLab audit ‘override’ logs nightly and file a QMS nonconformance; loop in pathologist-on-call, @sandraP88.

‌⁠‍⁠​‍​‍‌⁠‌​​‍​‍​⁠‍‍​‍​‍‌‍⁠​‌‍​‌‌‍​‍‌⁠‌​‌‍‌‌‌‍​⁠‌‍‍​‌‍⁠‍‌‍‍‌‌‍​⁠‌‍‍‌‌‍​‌‌‍⁠‍​‍​‍​‍⁠​​‍​‍‌‍‍⁠​‍​‍​⁠‍‍​‍​‍‌⁠​‍‌‍‌‌‌⁠​​‌‍⁠​‌⁠‍‌​‍​‍​‍⁠​​‍​‍‌‍‍‌‌‍‌​​‍​‍​⁠‍‍​⁠​‌​⁠​‌​⁠‍​​‍⁠​​‍​‍‌‍‌​​‍​‍​⁠‍‍​‍​‍​⁠​‍​⁠​​​⁠​‍​⁠‌‍​⁠​​​⁠​‌​⁠​​​⁠​‌​‍​‍​‍⁠​​‍​‍‌‍‍​​‍​‍​⁠‍‍​‍​‍‌⁠‍‌‌⁠​⁠‌‌⁠⁠‌​‌⁠‌​‍‍​⁠​‍‌‌‌​‌​‌⁠‌​‌‌‌‍⁠​‌‌‍‍‌⁠‌​‌​⁠​‌​​⁠‌‌‍​‌⁠​⁠​‍​‍‌⁠⁠‌​

We created a discrete ‘HMR — hold for manual review’ comment in SoftLab that auto opens a QMS event and stops the TAT clock; any override requires a second co-sign in that queue before release. If IT won’t add the hard stop, we kept a tiny refusal log (accession + reason) and filed it daily — would Ops agree to exclude these ‘HMR’ cases from TAT so you’re not graded on them?

‌⁠‍⁠​‍​‍‌⁠‌​​‍​‍​⁠‍‍​‍​‍‌‍⁠​‌‍​‌‌‍​‍‌⁠‌​‌‍‌‌‌‍​⁠‌‍‍​‌‍⁠‍‌‍‍‌‌‍​⁠‌‍‍‌‌‍​‌‌‍⁠‍​‍​‍​‍⁠​​‍​‍‌‍‍⁠​‍​‍​⁠‍‍​‍​‍‌⁠​‍‌‍‌‌‌⁠​​‌‍⁠​‌⁠‍‌​‍​‍​‍⁠​​‍​‍‌‍‍‌‌‍‌​​‍​‍​⁠‍‍​⁠​‌​⁠​‌​⁠‍​​‍⁠​​‍​‍‌‍‌​​‍​‍​⁠‍‍​‍​‍​⁠​‍​⁠​​​⁠​‍​⁠‌‍​⁠​​​⁠​‌​⁠​‌​⁠​​​‍​‍​‍⁠​​‍​‍‌‍‍​​‍​‍​⁠‍‍​‍​‍‌‍​‌​⁠‍​‌‍⁠⁠​⁠‍​‌​⁠⁠‌⁠‍​​⁠​⁠‌‌​‍‌‍‌⁠‌​‍⁠‌⁠‍‍‌‍⁠‌‌⁠​‍‌‍‌‌‌​⁠‌​⁠​‌​‍​‍‌⁠⁠‌​